Brief: Eastgate Biotech Receives Regulatory Approval To Initiate A Phase III 90-Day Clinical Trial On Insugin, Its Liquid Insulin Mouth Rinse Solution

Eastgate Biotech

25/09/2019 14:19

Sept 25 (Reuters) - Eastgate Biotech Corp  ETBI.PK :
    * EASTGATE BIOTECH RECEIVES REGULATORY APPROVAL TO INITIATE
A
PHASE III 90-DAY CLINICAL TRIAL ON INSUGIN, ITS LIQUID INSULIN
MOUTH RINSE SOLUTION

Source text for Eikon:  ID:nGNX7w3wx9 
Further company coverage:  ETBI.PK 

 ((Reuters.Briefs@thomsonreuters.com;))